Table 1

Patient and hospitalization characteristics

MUMC

OMC

CHE

Total

Homogeneity$


Total questionnaires (N)

447

230

207

884

Response rate (%)

72

84

81

77

Admitted patients (N)

53

34

36

123

Total hospitalizations (N)

61

47

51

159

Age (yr)

71 [SD = 10.4]

75 [SD = 7.6]

71 [SD = 8.5]

72 [SD = 9.2]

0.87

Disease duration (yr)

9.6 [SD = 7.0]

9.1 [SD = 7.2]

10.7 [SD = 6.9]

9.8 [SD = 7.0]

0.49

LED-value (mg/day)

554

761

855

711

0.004

N*

%*

N*

%*

N*

%*

N*

%*

Gender

Women

28

46

15

32

14

28

57

36

0.04

Men

33

54

32

68

37

72

102

64

Hoehn&Yahr

stage < III

24

39

20

43

13

25

57

36

0.12

stage III, IV

33

54

25

53

33

65

91

57

0.32

stage V

3

5

2

4

5

10

10

6

0.33

Don't know/missing

1

2

0

0

0

0

1

1

On-off fluctuations

Yes

27

44

14

30

21

41

62

39

0.61

No

33

54

33

70

30

59

96

60

Don't know/missing

1

2

0

0

0

0

1

1

Cognitive problems

Yes

20

33

24

51

29

57

72

46

0.009

No

41

67

23

49

22

43

86

54

Don't know/missing

0

0

0

0

0

0

0

0

Deterioration during admission

Yes

13

21

10

21

11

22

34

21

0.84

No

45

74

30

64

35

69

110

69

Don't know/missing

3

5

7

15

5

10

15

9

Complications during admission

None

40

66

30

64

35

69

105

66

0.76

One or more complications

21

34

15

32

16

31

52

33

0.30

Confusion

13

21

11

23

11

22

35

22

0.91

Urinary tract infection

4

7

6

13

2

4

12

8

0.70

Emotional disturbance

6

10

0

0

0

0

6

4

0.004

Pneumonia

0

0

2

4

2

4

4

3

0.17

Memory complaints

2

3

0

0

3

6

5

3

0.50

Falls

0

0

2

4

0

0

2

1

0.87

Other

2

3

0

0

3

6

5

3

0.50

Don't know/missing

0

0

2

4

0

0

2

1

Medication distribution

Good

40

66

29

62

39

76

108

68

0.15

Bad

18

30

16

34

8

16

42

26

Don't know/missing

3

5

2

4

4

8

9

6

Surgery

Yes

39

64

21

45

31

61

91

57

0.63

No

22

36

26

55

20

39

68

43

Don't know/missing

0

0

0

0

0

0

0

0

Ward

Neurologic

11

18

6

13

11

22

28

18

0.68

Non-neurologic

48

79

41

87

39

76

128

81

Don't know/missing

2

3

0

0

1

2

3

2

Involvement of paramedics

Yes

23

38

29

62

8

16

60

38

0.025

No

34

56

14

30

41

80

89

56

Don't know/missing

4

7

4

9

2

4

10

6

Consultation of PD nurse specialist#

Yes

14

23

20

43

5

10

39

25

0.14

No

45

74

24

51

44

86

113

71

Don't know/missing

2

3

3

6

2

4

7

4


* N; number and percentage of total admissions

# Non-neurological ward

$ For homogeneity between different centres the Pearson Correlation and Spearman's rho tests were used. P-values are shown. P-value < 0.05 is considered significant.

Abbreviations: MUMC, Maastricht University Medical Centre; OMC, Orbis Medical Centre; CHE, Catharina Hospital Eindhoven; N, number; SD, standard deviation; LED-value, Levodopa Equivalent Dose; PD, Parkinson's disease

Gerlach et al. BMC Neurology 2012 12:13   doi:10.1186/1471-2377-12-13

Open Data